Biotechnology company
Issues related to the 340B Drug Discount Program; drug pricing; and general education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to diversity in clinical trials. Funding for flu preparedness and the SNS. Issues related to the 340B Drug Discount Program; drug pricing; and general education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to diversity in clinical trials. Funding for flu preparedness and the SNS. Issues relating to privacy and securing medical research data and personal health information of patients/consumers.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch)
LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch